Tosti-Croce C, Rinaldi R, Massaria M, Lomurno A, Felicioli T, Sciarra F
Istituto di Clinica Medica V, Università La Sapienza, Rome, Italy.
Clin Exp Hypertens A. 1992;14(6):1083-94. doi: 10.3109/10641969209038194.
19-hydroxy-androstenedione (19-OH-A), a C19 steroid, is an amplifier of the sodium retaining action of aldosterone under the control of ACTH and renin-angiotensin system. These findings suggest that 19-OH-A may be involved in the regulation of hydroelectrolyte balance and blood pressure. Aim of the present study was to examine the behaviour of 19-OH-A in normal volunteers (N) and in patients with Essential Hypertension (EH) in basal conditions and after dynamic tests such as postural changes, physical exercise and ACTH administration. The significant increase in 19-OH-A after ACTH confirms its adrenal origin. During bicycle exercise the significant increase in plasma catecholamines, renin-activity, aldosterone, blood pressure and heart rate at maximum effort was not associated with a parallel increase in 19-OH-A. No significant differences were found in plasma 19-OH-A levels between N and EH patients both in basal conditions and after dynamic tests. Therefore, our findings seem to exclude an important role of 19-OH-A in the pathogenesis of EH.
19-羟基雄烯二酮(19-OH-A)是一种C19类固醇,在促肾上腺皮质激素(ACTH)和肾素-血管紧张素系统的调控下,它是醛固酮保钠作用的增强剂。这些发现表明19-OH-A可能参与水电解质平衡和血压的调节。本研究的目的是检测正常志愿者(N)和原发性高血压患者(EH)在基础状态下以及在诸如体位改变、体育锻炼和注射ACTH等动态试验后19-OH-A的变化情况。注射ACTH后19-OH-A显著增加证实了其肾上腺来源。在自行车运动期间,最大负荷时血浆儿茶酚胺、肾素活性、醛固酮、血压和心率显著增加,但与19-OH-A的平行增加无关。在基础状态和动态试验后,N组和EH组患者血浆19-OH-A水平均未发现显著差异。因此,我们的研究结果似乎排除了19-OH-A在EH发病机制中的重要作用。